Atlas Trials

Treatment of Cancer With Immune Checkpoint Inhibition Therapy Boosted by High Intensity Focused Ultrasound Histotripsy

Clinical trial NCT06524570 · RECRUITING

Trial details

NCT number
NCT06524570
Sponsor
UMC Utrecht
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
CancerMetastatic Cancer
Start date
2024-07-26
Primary completion
2030-08-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.